Cargando…
Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach
Hepatocellular carcinoma (HCC) accompanied by severe liver dysfunction is a serious disease, which results in altered hepatic clearance. Generally, maintenance doses depend upon drug clearance, so individual dosage regimens should be customized for HCC patients based on the condition of patients. Ba...
Autores principales: | Gao, Jie, Zhou, Jun, He, Xiao-Pei, Zhang, Yun-Fei, Gao, Na, Tian, Xin, Fang, Yan, Wen, Qiang, Jia, Lin-Jing, Jin, Han, Qiao, Hai-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053749/ https://www.ncbi.nlm.nih.gov/pubmed/27086920 http://dx.doi.org/10.18632/oncotarget.8704 |
Ejemplares similares
-
Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma
por: Zhou, Jun, et al.
Publicado: (2016) -
Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs
por: Gao, Jie, et al.
Publicado: (2017) -
Correlation of Cytochrome P450 Oxidoreductase Expression with the
Expression of 10 Isoforms of Cytochrome P450 in Human Liver
por: Zhang, Hai-Feng, et al.
Publicado: (2016) -
In Vitro and In Vivo Effect of Xylopic Acid on Cytochrome P450 Enzymes
por: Agbenyeku, Mary A., et al.
Publicado: (2022) -
Cytochrome P450-Based Drug-Drug Interactions of Vonoprazan In Vitro and In Vivo
por: Wang, Yiran, et al.
Publicado: (2020)